Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study.
Herder C, Peltonen M, Koenig W, Kräft I, Müller-Scholze S, Martin S, Lakka T, Ilanne-Parikka P, Eriksson JG, Hämäläinen H, Keinänen-Kiukaanniemi S, Valle TT, Uusitupa M, Lindström J, Kolb H, Tuomilehto J. Herder C, et al. Among authors: muller scholze s. Diabetes. 2006 Aug;55(8):2340-6. doi: 10.2337/db05-1320. Diabetes. 2006. PMID: 16873699 Clinical Trial.
Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4).
Herder C, Haastert B, Müller-Scholze S, Koenig W, Thorand B, Holle R, Wichmann HE, Scherbaum WA, Martin S, Kolb H. Herder C, et al. Among authors: muller scholze s. Diabetes. 2005 Dec;54 Suppl 2:S11-7. doi: 10.2337/diabetes.54.suppl_2.s11. Diabetes. 2005. PMID: 16306328
Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4).
Herder C, Kolb H, Koenig W, Haastert B, Müller-Scholze S, Rathmann W, Holle R, Thorand B, Wichmann HE. Herder C, et al. Among authors: muller scholze s. Diabetes Care. 2006 Feb;29(2):368-71. doi: 10.2337/diacare.29.02.06.dc05-1474. Diabetes Care. 2006. PMID: 16443889
Inflammation and type 2 diabetes: results from KORA Augsburg.
Herder C, Illig T, Rathmann W, Martin S, Haastert B, Müller-Scholze S, Holle R, Thorand B, Koenig W, Wichmann HE, Kolb H; KORA Study Group. Herder C, et al. Among authors: muller scholze s. Gesundheitswesen. 2005 Aug;67 Suppl 1:S115-21. doi: 10.1055/s-2005-858252. Gesundheitswesen. 2005. PMID: 16032528 Clinical Trial.
Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4).
Herder C, Müller-Scholze S, Rating P, Koenig W, Thorand B, Haastert B, Holle R, Illig T, Rathmann W, Seissler J, Wichmann HE, Kolb H. Herder C, et al. Among authors: muller scholze s. Eur J Endocrinol. 2006 Feb;154(2):311-7. doi: 10.1530/eje.1.02090. Eur J Endocrinol. 2006. PMID: 16452546
Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus.
Hanifi-Moghaddam P, Kappler S, Seissler J, Müller-Scholze S, Martin S, Roep BO, Strassburger K, Kolb H, Schloot NC. Hanifi-Moghaddam P, et al. Among authors: muller scholze s. Diabet Med. 2006 Feb;23(2):156-63. doi: 10.1111/j.1464-5491.2005.01743.x. Diabet Med. 2006. PMID: 16433713
13 results